![]()
The Business Research Company’s Pulmonary Hypertension Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON , UNITED KINGDOM, November 17, 2026 /EINPresswire.com/ — The pulmonary hypertension market has experienced significant growth recently, driven by advancements in treatments and increased awareness of the condition. As the healthcare landscape evolves, the demand for more effective diagnostic and therapeutic options continues to rise, setting the stage for notable expansion in this field over the coming years.
Pulmonary Hypertension Market Size and Projected Growth
The market for pulmonary hypertension is on a strong upward trajectory. It is expected to increase from $1.42 billion in 2025 to $1.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.3%. This growth has been fueled by a rising number of pulmonary hypertension cases, enhanced awareness about pulmonary vascular diseases, greater availability of specialized therapies, improvements in diagnostic tools, and the increasing use of combination treatment methods.
Download a free sample of the pulmonary hypertension market report:
https://www.thebusinessresearchcompany.com/sample_request?id=79345198&type=smp&name=Pulmonary%20Hypertension%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Looking ahead, the pulmonary hypertension market is forecasted to continue its rapid growth, reaching $2.18 billion by 2030 with a CAGR of 8.9%. Key drivers of this expansion include a robust pipeline of novel therapies, wider implementation of early detection techniques, a heightened focus on personalized treatment strategies, growing adoption of remote patient monitoring technologies, and greater investment in rare disease drug development. Emerging trends during this period encompass targeted pulmonary vasodilator therapies, earlier and more accurate diagnoses, use of combination therapies for managing the disease, customized treatments based on disease origins, and comprehensive long-term monitoring and risk assessment.
Understanding Pulmonary Hypertension and Its Impact
Pulmonary hypertension is a progressive heart and lung disorder marked by abnormally high blood pressure in the arteries that carry blood from the heart to the lungs. This elevated pressure increases the workload on the right side of the heart, which can eventually cause right heart failure if untreated. The condition has various causes and presents symptoms such as shortness of breath, fatigue, chest pain, and decreased ability to exercise.
View the full pulmonary hypertension market report:
https://www.thebusinessresearchcompany.com/report/pulmonary-hypertension-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Factors Promoting Market Expansion in Pulmonary Hypertension
One of the main forces driving the pulmonary hypertension market is the increasing use of targeted therapies. These treatments aim at specific biological pathways or molecular processes responsible for disease progression, offering more precise and effective care. The rise in targeted therapies is supported by advances in biomarker-based diagnostics, which allow for better patient selection and enhance treatment success.
Additionally, targeted therapy adoption is improving disease management by slowing progression and personalizing treatment. For example, in April 2025, the American Society of Gene & Cell Therapy (ASGCT) reported that the number of gene therapies in Phase II trials had risen to 306 in the first quarter of 2024. This demonstrates the growing momentum behind precision therapies, further propelling the pulmonary hypertension market forward.
Regional Market Overview for Pulmonary Hypertension
In 2025, North America held the largest share of the pulmonary hypertension market, reflecting strong healthcare infrastructure and high awareness levels. Meanwhile, the Asia-Pacific region is expected to emerge as the fastest-growing market during the forecast period. Other key regions covered in the market analysis include South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market trends.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery
